Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Yong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0513-8941; OpenAlex author ID A5100419841, A5138164546. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 6

  1. Plasma Proteomic Profiling Identifies Candidate Biomarkers for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/jcla.70313↗
  2. Key Mucins in Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Biliary Tract Cancer: A Meta-Analysis. Last author DOI 10.1007/s43657-025-00288-9↗
  3. Proteomics in pancreatic cancer. Last author DOI 10.1186/s40364-025-00805-y↗
  4. Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment. Co-author DOI 10.3389/fimmu.2025.1585858↗
  5. Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis. Last author DOI 10.1186/s12014-024-09522-4↗
  6. Construction of an efferocytosis-related long non-coding ribonucleic acid scoring system to predict clinical outcome and immunotherapy response in pancreatic a… Co-author DOI 10.1016/j.bbrep.2023.101540↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Jin · 2 shared papers, 2024–2026 · strength 0.61
  2. Ang Li · 2 shared papers, 2024–2026 · strength 0.61
  3. Fei Cai · 2 shared papers, 2025–2026 · strength 0.59
  4. Lelang Xiang · 1 shared paper, 2026 · strength 0.36
  5. Yuxi Qiao · 1 shared paper, 2025 · strength 0.33
  6. Qian Dong · 1 shared paper, 2025 · strength 0.33
  7. Ailin Wei · 1 shared paper, 2024 · strength 0.26
  8. Chengsheng Zhou · 1 shared paper, 2023 · strength 0.22
  9. J Zhang · 1 shared paper, 2023 · strength 0.22
  10. Ang Li · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.